Animal models for the study of adenosine receptor function

被引:125
作者
Yaar, R
Jones, MR
Chen, JF
Ravid, K
机构
[1] Boston Univ, Sch Med, Dept Biochem, Whitaker Cardiovasc Inst,Dept Neurol, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Pharmacol, Whitaker Cardiovasc Inst,Dept Neurol, Boston, MA USA
关键词
D O I
10.1002/jcp.20138
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Adenosine receptors represent a family of G-protein coupled receptors that are ubiquitously expressed in a wide variety of tissues. This family contains four receptor subtypes: A1 and A3, which mediate inhibition of adenylyl cyclase and A2a and A2b, which mediate stimulation of this enzyme. Currently, all receptor subtypes have been genetically deleted in mouse models except for the A2b adenosine receptor, and some have been overexpressed in selective tissues of transgenic mice. Studies involving these transgenic mice indicated that receptor levels are rate limiting, as effects were amplified upon increases in receptor level. The knockout models pointed to clusters of activities related to the physiologies of the cardiovascular and the nervous systems, which are either reduced or enhanced upon specific receptor deletion. Interestingly, the trend of effects on these systems is similar in the A1 and A3 adenosine receptor knockout mice and opposite to the effects observed in the A2a adenosine receptor knockout model. This review summarizes in vitro studies on pathways affected by each adenosine receptor, and primarily focuses on the above in vivo models generated to investigate the physiologic role of adenosine receptors. Furthermore, it illustrates the need for multiple adenosine receptor subtype deficiency studies in mice and the deletion of the A2b subtype.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 161 条
  • [1] Abbracchio MP, 2001, ANN NY ACAD SCI, V939, P63
  • [2] Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038
  • [3] THE STIMULATORY EFFECT OF CALPACTIN (ANNEXIN-II) ON CALCIUM-DEPENDENT EXOCYTOSIS IN CHROMAFFIN CELLS - REQUIREMENT FOR BOTH THE N-TERMINAL AND CORE DOMAINS OF P36 AND ATP
    ALI, SM
    BURGOYNE, RD
    [J]. CELLULAR SIGNALLING, 1990, 2 (03) : 265 - 276
  • [4] Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist
    Aoyama, S
    Kase, H
    Borrelli, E
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (15) : 5848 - 5852
  • [5] Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes:: studies of cells from A2A-receptor-gene-deficient mice
    Armstrong, JM
    Chen, JF
    Schwarzschild, MA
    Apasov, S
    Smith, PT
    Caldwell, C
    Chen, P
    Figler, H
    Sullivan, G
    Fink, S
    Linden, J
    Sitkovsky, M
    [J]. BIOCHEMICAL JOURNAL, 2001, 354 : 123 - 130
  • [6] ADENOSINE RECEPTOR SPECIFICITY IN PRECONDITIONING OF ISOLATED RABBIT CARDIOMYOCYTES - EVIDENCE OF A(3) RECEPTOR INVOLVEMENT
    ARMSTRONG, S
    GANOTE, CE
    [J]. CARDIOVASCULAR RESEARCH, 1994, 28 (07) : 1049 - 1056
  • [7] ARMSTRONG S, 1995, CARDIOVASC RES, V29, P647, DOI 10.1016/S0008-6363(96)88635-4
  • [8] Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
    Ascherio, A
    Zhang, SMM
    Hernán, MA
    Kawachi, I
    Colditz, GA
    Speizer, FE
    Willett, WC
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (01) : 56 - 63
  • [9] Cloning, characterisation and chromosomal assignment of the human adenosine A3 receptor (ADORA3) gene
    Atkinson, MR
    TownsendNicholson, A
    Nicholl, JK
    Sutherland, GR
    Schofield, PR
    [J]. NEUROSCIENCE RESEARCH, 1997, 29 (01) : 73 - 79
  • [10] Auchampach JA, 1997, CIRC RES, V80, P800